Christina Smolke

CEO and Co-Founder of Antheia and Adjunct Professor of Bioengineering at Stanford University

Dr. Smolke led the breakthrough research at Stanford to engineer baker’s yeast to produce highly-complex, plant-based essential medicines. She founded Antheia to transform pharmaceutical supply chains by leveraging synthetic biology for a more efficient, sustainable, and rapid-response model for drug manufacturing.